Science Explorer Back to mapMap
Discussion
Researcher · Enanta Pharmaceuticals (United States) · United States

Mary Chau

Mary Chau publishes mostly in Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism, on topics such as Liver Disease Diagnosis and Treatment, Hormonal Regulation and Hypertension and Congenital heart defects research.

OpenAlex
World rank
#6,324,557
of 7,710,434 ranked researchers
Rank in United States
#1,504,219
of 1,627,098
Works
17
Citations
17
Citations per work
1.0
h-index
1
i10-index 1Top 99.7% in Epidemiology
Mary Chau

What does Mary Chau research?

Mary Chau's work is mostly in Medicine (60%), Biochemistry, Genetics and Molecular Biology (7%).

Health Sciences: 10 works · 60.0% of their workMedicine: 10 works · 60.0% of their workEpidemiology: 4 works · 22.5% of their workEndocrinology, Diabetes and Metabolism: 2 works · 12.5% of their workHepatology: 2 works · 12.5% of their workSurgery: 1 works · 7.5% of their workHematology: 1 works · 5.0% of their workEverything else: 6 works · 32.5% of their workLife Sciences: 1 works · 7.5% of their workBiochemistry, Genetics and Molecular Biology: 1 works · 7.5% of their workMolecular Biology: 1 works · 7.5% of their workTHEIR WORKMary Chau17works
Life Sciences7%Health Sciences60%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1060.0%
  2. Everything else632.5%
    1. Biochemistry, Genetics and Molecular Biology17.5%
  1. 1Epidemiology22% of their works
  2. 2Hepatology12% of their works
  3. 3Endocrinology, Diabetes and Metabolism12% of their works
  4. 4Surgery8% of their works
  5. 5Molecular Biology8% of their works
  6. 6Hematology5% of their works

Research topics

Which keywords describe Mary Chau's research?

The keywords of their largest research topics: Metabolic Syndrome, Hepatic Steatosis, Insulin Resistance, NAFLD, NASH, Hypertension, Aldosterone and Primary Aldosteronism.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Metabolic Syndrome133 topics
  2. Hepatic Steatosis102 topics
  3. Insulin Resistance102 topics
  4. NAFLD81 topic
  5. NASH81 topic
  6. Hypertension52 topics
  7. Aldosterone31 topic
  8. Primary Aldosteronism31 topic
  9. Autoimmune Hepatitis21 topic
  10. Cardiomyocyte Renewal21 topic
  11. Decellularization21 topic
  12. Extracellular Matrix21 topic
  13. Fructose21 topic
  14. Heart Regeneration21 topic
  15. Nuclear Receptors22 topics
  16. Obesity21 topic
  17. Primary Biliary Cirrhosis21 topic
  18. Acute Promyelocytic Leukemia11 topic
  19. Estrogen11 topic
  20. Receptor11 topic
  21. Retinoic Acid11 topic

Where does Mary Chau work?

Mary Chau's main affiliation in the publication record is Enanta Pharmaceuticals (United States), United States.

How many publications and citations does Mary Chau have?

OpenAlex counts 17 works and 17 citations for Mary Chau, an h-index of 1, ranking #6,324,557 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mary Chau. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.